Absence of copy number gain of EGFR: A possible predictive marker of long-term response to afatinib. Nakamura T, Sato A, Nakashima C, Abe T, et al. Cancer Sci 2023;114:1045-1055.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nakamura T, Sato A, Nakashima C, Abe T, et al. Absence of copy number gain of EGFR: A possible predictive marker of long-term response to afatinib. Cancer Sci 2023;114:1045-1055.
PMID: 36382532